Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 75,000 shares at $91.94 ($4.7M) on 2021-03-15, disclosed to the SEC on 2021-03-16.
Open-market sale of $4.7M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.90 | 25,000 | $73K | 1.5% |
| 2 | $90.89 | 3,957 | $360K | 7.7% |
| 3 | $90.89 | 3,957 | $360K | 7.7% |
| 4 | $91.94 | 8,416 | $774K | 16.5% |
| 5 | $91.94 | 8,416 | $774K | 16.5% |
| 6 | $92.64 | 8,404 |
| $779K |
| 16.6% |
| 7 | $92.64 | 8,404 | $779K | 16.6% |
| 8 | $93.75 | 3,205 | $300K | 6.4% |
| 9 | $93.75 | 3,205 | $300K | 6.4% |
| 10 | $94.59 | 1,018 | $96K | 2.1% |
| 11 | $94.59 | 1,018 | $96K | 2.1% |
| Total | $62.53 avg | 75,000 | $4.7M | 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |